Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
- PMID: 29753029
- PMCID: PMC6200630
- DOI: 10.1016/j.jid.2018.04.025
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
Abstract
BRAF and NRAS mutations arise early in melanoma development, but their associations with low-penetrance melanoma susceptibility loci remain unknown. In the Genes, Environment and Melanoma Study, 1,223 European-origin participants had their incident invasive primary melanomas screened for BRAF/NRAS mutations and germline DNA genotyped for 47 single-nucleotide polymorphisms identified as low-penetrant melanoma-risk variants. We used multinomial logistic regression to simultaneously examine each single-nucleotide polymorphism's relationship to BRAF V600E, BRAF V600K, BRAF other, and NRAS+ relative to BRAF-/NRAS- melanoma adjusted for study features. IRF4 rs12203592*T was associated with BRAF V600E (odds ratio [OR] = 0.59, 95% confidence interval [CI] = 0.43-0.79) and V600K (OR = 0.65, 95% CI = 0.41-1.03), but not BRAF other or NRAS+ melanoma. A global test of etiologic heterogeneity (Pglobal = 0.001) passed false discovery (Pglobal = 0.0026). PLA2G6 rs132985*T was associated with BRAF V600E (OR = 1.32, 95% CI = 1.05-1.67) and BRAF other (OR = 1.82, 95% CI = 1.11-2.98), but not BRAF V600K or NRAS+ melanoma. The test for etiologic heterogeneity (Pglobal) was 0.005. The IRF4 rs12203592 associations were slightly attenuated after adjustment for melanoma-risk phenotypes. The PLA2G6 rs132985 associations were independent of phenotypes. IRF4 and PLA2G6 inherited genotypes may influence melanoma BRAF/NRAS subtype development.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
No potential conflicts of interest were disclosed.
References
-
- Akiba S, Sato T. Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull. 2004;27(8):1174–8. - PubMed
-
- Autier P, Boniol M, Severi G, Giles G, Cattaruzza MS, Luther H, et al. The body site distribution of melanocytic naevi in 6-7 year old European children. Melanoma Res. 2001;11(2):123–31. - PubMed
-
- Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004;15(9):957–65. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 ES010126/ES/NIEHS NIH HHS/United States
- U01 CA083180/CA/NCI NIH HHS/United States
- T32 GM008169/GM/NIGMS NIH HHS/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- P01 CA206980/CA/NCI NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- R01 CA098438/CA/NCI NIH HHS/United States
- R01 CA112243/CA/NCI NIH HHS/United States
- R03 CA173806/CA/NCI NIH HHS/United States
- R01 CA112524/CA/NCI NIH HHS/United States
- R03 CA125829/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- K07 CA102096/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
